Hainan Beikang Pharmaceutical Technology Co., Ltd.

Main research purpose: This study uses vortioxetine hydrobromide tablets (10 mg) produced by Chengdu Beite Pharmaceutical Co., Ltd. as the test preparation and vortioxetine hydrobromide tablets (10 mg) (trade name: Xindayue®) produced by H.Lundbeck A/S as the reference preparation to evaluate the bioequivalence of the test preparation and the reference preparation when administered under fasting and postprandial conditions. Secondary research purpose: Observe the safety of the test preparation and the reference preparation in healthy subjects.

Main research purpose: This study uses dapagliflozin tablets (10 mg) held by Hainan Beikang Pharmaceutical Technology Co., Ltd. as the test preparation and the original imported dapagliflozin tablets (10 mg, trade name: Andatang®) held by AstraZeneca AB as the reference preparation to evaluate the bioequivalence of the test preparation and the reference preparation when administered under fasting and postprandial conditions. Secondary research purpose: Observe the safety of the test preparation and the reference preparation in healthy subjects.